These findings clearly demonstrate that the MTHFR C677T heterozygous mutation is prevalent in nearly all stroke patient samples and suggest a very low likelihood of a combination between this mutation and other SNP mutations in the other indicated genes. This evidence concerns the gene MTHFR and stroke disorder.